CAbotégravir LENacapavir DUal Long Acting

Clinical trial NCT06657885 · WITHDRAWN

Trial details

NCT number: NCT06657885
Sponsor: Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

HIV1 Infection Multi-treated Patients Who Have Received Multiple Lines of Antiretroviral Treatment CABOTEGRAVIR LENACAPAVIR Stable Oral Antiretroviral Treatment for at Least 6 Months

Start date: 2025-01-15
Primary completion: 2026-07-15
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.